<!doctype html>
<html>

<head>
  <title>Breast Cancer Area: 500K Scientists with Datasets and Methods.</title>
  <meta charset="utf-8" name="viewport" content="width=device-width, initial-scale=1">
  <link href="https://use.fontawesome.com/releases/v5.2.0/css/all.css" media="screen" rel="stylesheet"
    type="text/css" />
  <link href="css/frame.css" media="screen" rel="stylesheet" type="text/css" />
  <link href="css/controls.css" media="screen" rel="stylesheet" type="text/css" />
  <link href="css/custom.css" media="screen" rel="stylesheet" type="text/css" />
  <link href='https://fonts.googleapis.com/css?family=Open+Sans:400,700' rel='stylesheet' type='text/css'>
  <link href='https://fonts.googleapis.com/css?family=Open+Sans+Condensed:300,700' rel='stylesheet' type='text/css'>
  <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700" rel="stylesheet">
  <script src="https://ajax.googleapis.com/ajax/libs/jquery/3.3.1/jquery.min.js"></script>
  <script src="js/menu.js"></script>
  <script src="js/footer.js"></script>
  <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/font-awesome/4.4.0/css/font-awesome.min.css">
  <style>
    .menu-index {
      color: rgb(255, 255, 255) !important;
      opacity: 1 !important;
      font-weight: 700 !important;
    }
  </style>
</head>

<body>
  <div class="menu-container"></div>
  <div class="content-container">
    <div class="content">
      <div class="content-table flex-column">
        <!--Start Header-->
        <!-- <div class="banner"
      style="background: url('img/dummy-background.jpeg') no-repeat center; background-size: cover; height: 300px;">
    </div> -->
        <div class="banner">
          <div class="banner-table flex-column">
            <div class="flex-row">
              <div class="flex-item flex-column">
                <h2 class="add-top-margin-small">Breast Cancer Area: 500K Scientists with Datasets and Methods. &nbsp; (Use wide screen devices to get the best user experience ! ) <a
                    href="https://github.com/jiaweixu98/MethodsDatasetsScientists"
                    style="text-decoration:none;font-size:15px;color:#ffffff;"> <b>
                      <i class="fa fa-github"></i> Github repository </b>
                  </a></h2>
                <p class="text">
                  Explore our interactive graph to see how breast cancer scientists work. Learn about their knowledge,
                  the data they use, and the <a href="https://bridge2ai.org/"
                    style="text-decoration:none; color:#FFA15A;">
                    <b>Bridge2AI</b></a> scientists leading the way.
                </p>
                <p class="text">
                  We use <a href="https://dl.acm.org/doi/pdf/10.1145/3292500.3330961"
                    style="text-decoration:none;color:#FFA15A;"> <b>HetGNN (Heterogeneous Graph Neural
                      Network)</b></a>
                  to represent node embeddings in the Breast Cancer area with the <a
                    href="https://www.nature.com/articles/s41597-020-0543-2"
                    style="text-decoration:none;color:#FFA15A;">
                    <b>Pubmed Knowledge Graph</b></a>
                  Dataset. This includes <b>five</b> kinds of nodes: scientists, OBI methods, datasets, papers, and bioentities. Their
                  relationships include writing, collaboration, mention, citing, and use.

                  <br><br>We visualized <b> scientists</b>, <b>methods</b>, and<b> datasets </b>using K-means clustering (k=5) and T-SNE.
                  The
                  cluster labels are based on abstracts, titles, TF-IDF, and chatGPT.
                  <br><br> At the bottom of this page, we list the <b>main words of each cluster</b>, including bio entities clusters.
                  <br><br>
                  <b> How to interact with the graph? </b>
                </p>
                <ol style="text-decoration:none;color:#ffffff;">
                  <li>Use the mouse wheel or the ‘+’ and ‘-’ buttons on the top right of the canvas to <b>zoom in and
                      out</b>.</li>
                  <li>Hover over a node to see <b>details</b>.</li>
                  <li>Double-click to autoscale and recover default settings.</li>
                  <li>Click the legends to hide/show groups of nodes.</li>
                  <li>Other tools are located on the top right of the canvas.</li>
                </ol>
              </div>
            </div>
          </div>
        </div>
        <!--End Header-->
        <!--Start Text with Iframe-->
        <div class="flex-row">
          <div class="flex-item flex-column">
            <!-- <h2>How breast cancer scientists work?</h2> -->

            <iframe class="iframe-in-body" scrolling="no"
              src="https://jiaweixu98.github.io/pagesRepo/subset bio dataset and method.html"></iframe>
              <hr>
            <h3>Below are the main words of each cluster derived from tf-idf, including and bio entities clusters. </h3>
            <p class="text">
              <ul>
                <li>
                  <h3 style="color:#636EFA ;">Cluster 0 &nbsp;&nbsp; Therapies for Breast Cancer Fatigue </h3>
                </li>
                <ul>
                  <!-- <p>Bioentities: 'leptin', 'NF-κB', 'ATP', 'MAPK', 'DOX', 'AKT', 'MCF7', 'ERK', 'HBXIP', 'Bax', 'MTT',
                    'Bcl-2',
                    'oxygen', 'NF-B', 'CXCR4', 'STAT3', 'p38', 'anticancer', 'curcumin', 'siRNA', 'cisplatin', 'ERα',
                    'CSCs', 'mTOR',
                    'p21', 'PEG', 'PTX'</p> -->
                    <p><b>Reasoning: This cluster includes bio entities related to fatigue in breast cancer patients
                        (attentional fatigue and mood/anxiety disorder) as well as potential therapeutic options for
                        managing fatigue (modafinil and rebamipide). Other bio entities suggest potential novel
                        therapies for breast cancer, including motesanib, a drug that inhibits tumor growth, and FGF-21,
                        a protein that may reduce inflammation and promote metabolic health. Overall, this cluster
                        suggests a focus on developing innovative strategies for managing fatigue in breast cancer
                        patients, as well as identifying novel therapeutic targets for breast cancer treatment.</b></p>
                  <p>Bio Entities: 'motesanib', 'attentional fatigue', 'balugrastim', 'Panagen', '"cancers of the
                    mouth', 'efaproxiral', 'ADR-529', 'FVT', 'EPMs', 'modafinil', 'HCWs', 'BAT8001', 'D/deaf', 'IFX',
                    'rs3104746', 'SpM', 'MYL-1401H', 'proneurotensin', 'CROF', 'TEXT', 'esorubicin', 'mood/anxiety
                    disorder', 'IMID', 'BCD-022', 'adiposity-related cancers', 'comorbid diseases', 'levofolinic acid',
                    'HSS', 'YACSs', 'degarelix', 'DPTS', '15-F(2t)-IsoP', 'rebamipide', 'SpA', 'RAHD', 'pHF', 'Paullinia
                    cupana', 'Capilen', 'Ro 25-8315', 'LC-BC', 'FGF-21', 'rs13385191', 'CHESS', 'tubal sterilization',
                    'SARS-CoV-2 infection', 'BPM31543', 'Healthcare', 'HVOD', 'BCMO1', 'PERANTARA'
                  </p>
                </ul>

                <li>
                  <h3 style="color:#EF553B ;">Cluster 1 &nbsp;&nbsp; Molecular Pathways of Breast Cancer </h3>
                </li>
                <ul>
                  <p><b>This cluster of scientists appears to be focused on molecular biology and genetics of breast
                      cancer. The bio entities included are mainly genes, proteins and microRNAs which play important
                      roles in various cellular processes such as cell cycle, DNA repair, proliferation, and
                      differentiation. The cluster includes genes like Palb2, CLDN6, Runx1, TNFAIP8, and proteins like
                      HEXIM1, PHF8, and Rab25, which are known to be associated with breast cancer progression,
                      metastasis, and drug resistance. This cluster of scientists is likely investigating the underlying
                      molecular mechanisms of breast cancer and looking for potential therapeutic targets. Based on the
                      representative bio entities in Scientists Cluster 2, it seems to be focused on molecular and
                      genetic aspects of breast cancer. Many of the bio entities listed are genes, proteins, and
                      molecules involved in various cellular processes related to cancer development, such as cell
                      signaling, cell cycle regulation, and DNA repair. </b></p>
                  <!-- <p>Bioentities: 'overweight', 'folate', 'colorectal cancer', 'insulin', 'BCS', 'postmenopausal breast
                    cancer',
                    'Tamoxifen', 'testosterone', 'vitamin D', 'MD', 'depression', 'IGF-I', 'anxiety', 'prostate cancer',
                    'metformin',
                    'obesity', 'Participants', 'estrogens', '"breast', 'diabetes'</p> -->
                  <p>Bio Entities: 'CLDN6', 'ITIH5', 'ARTN', 'TRIM37', 'EGOT', 'VASH2', 'JMJD2A', 'USP22', 'USP37',
                    'TNFAIP8', 'Rab25', 'hnRNPA2', 'ZNF652', 'PHF8', 'LINC00511', 'MIR302', 'Runx1', 'CYGB', 'HEXIM1',
                    'Palb2', 'Mcs1a', 'RPH3AL', 'RNF144A', 'SOX2OT', 'p66ShcA', 'CDK3', 'SLC20A1', 'SMURF1', 'GIHCG',
                    'NCAPG', 'TReP-132', 'Bcl-3', 'linc-ROR', 'T798', 'TBC1D24', 'PGCCs', 'miR-873', 'miR-330-3p',
                    'RNF126', 'EglN2', 'FEAT', 'CHRNA5', 'PRKD3', 'TPM2', 'sohlh2', 'SNHG1', 'PES1', 'DHCR24', 'MITA',
                    'MLN51'</p>
                </ul>
                <li>
                  <h3 style="color:#00CC96 ;">Cluster 2 &nbsp;&nbsp; Therapeutic Targets
                  </h3>
                </li>
                <ul>
                  <p><b>This cluster includes a variety of potential targets for drug development, such as Fc variants,
                      CDK15, hinokitiol, and PIP4K2B, among others. These scientists are likely focusing on identifying
                      and studying new targets for potential therapies for breast cancer.</b></p>
                  <!-- <p>Bioentities: 'ESR1', 'CHEK2', 'CBC', 'ATM', 'BRCA1 mutation', 'PRS', 'ERBB2', 'RNA', 'c', 'AR',
                    'PALB2', 'breast
                    and ovarian cancer', 'BRCA2 mutations', 'miRNA', 'Estrogen', 'single nucleotide polymorphisms',
                    'TP53', 'familial
                    breast cancer', 'FGFR2'</p> -->
                  <p>Bio Entities: 'Fc variants', 'levofolinate', 'SVF cells', 'MAMDC2', 'LADR', '20K-hGH', 'gCIS',
                    'FcRIIb', 'RLS', 'CDK15', 'BIM-23052', 'Buxus sempervirens', 'IPMC', 'LIPH', 'FevA', 'Virulizin',
                    'HLA-E*0103', 'Oxi4503', '22K-hGH', 'PRES', 'E7130', 'ZNF704', 'Sm-153 EDTMP', 'peg-G',
                    'hinokitiol', 'WMJ-8-B', 'RNA2DNAlign', 'PIP4K2B', 'Mn12Ac', 'T2Rs', 'PCAA', 'OAB', 'IL-1ß', 'BRCa',
                    'anti amphiphysin', 'NBTE', 'SPCA1a', 'pp40', 'penehyclidine hydrochloride', 'DLK', 'rs4402960',
                    'inattentional blindness', 'damnacanthal', 'MIR34a', 'BNIPOSpm', 'ADH2', 'UiO-66', 'SMRL', 'OMF',
                    'DDX54'</p>
                </ul>
                <li>
                  <h3 style="color:#AB63FA ;">Cluster 3 &nbsp;&nbsp; Therapeutic Agents and Compounds</h3>
                </li>
                <ul>
                  <p><b>A cluster of scientific terms related to various substances and compounds, such as BMP9, NaPa,
                      DATS, tetrac, citral, sesamin, and As2S2, among others. The cluster also includes terms related to
                      biological processes and pathways, such as PFKFB4 and P2Y2R, as well as specific techniques and
                      methodologies, such as CT20p and DVDMS. Overall, it seems that this cluster relates to a broad
                      range of topics in the fields of biology, chemistry, and medicine.</b></p>
                  <!-- <p>Bioentities: '5-fluorouracil', 'early breast cancer', 'diarrhea', 'fulvestrant', 'SLN',
                    'pertuzumab',
                    'bevacizumab', 'taxanes', 'hormone receptor', 'G-CSF', 'palbociclib', 'CTC', 'zoledronic acid',
                    'everolimus', 'ABC',
                    'exemestane', 'gemcitabine', 'nausea', 'anthracyclines', 'methotrexate', 'neutropenia',
                    'vinorelbine',
                    'lapatinib',
                    'HER2-positive breast cancer', 'Trastuzumab', 'CMF', 'taxane', 'fluorouracil'</p> -->
                  <p>Bio Entities: 'BMP9', 'NaPa', 'DATS', 'tetrac', 'CT20p', 'Rac3', 'MONs', 'citral', 'AITC',
                    'sesamin', 'Asc', 'DMDD', 'DVDMS', 'MYOF', 'Rapa', 'RL2', 'JMJD3', 'PFKFB4', 'P2Y2R', 'nimbolide',
                    'GOX', 'PEG5K', 'NAF-1', 'Bi(2)O(3)', 'CTet', 'As2S2', 'BRBP1', 'Shp1', 'SeNPs', 'AuNR', 'α-TOS',
                    'Citral', 'PolyhHb', 'ILEI', 'furanodiene', 'HMME', 'CMDB7', 'Fe2O3', 'EriB', 'AIF-1', 'rhodium (II)
                    citrate', 'CPG2', 'hUC-MSCs', 'PDLLA', 'MoS(2)', 'ApppI', 'PDGF-D', 'Aplidin', 'ZYTP1', 'LYG-202'
                  </p>
                </ul>

                <li>
                  <h3 style="color:#FFA15A ;">Cluster 4 &nbsp;&nbsp; Breast Cancer Diagnostics and Biomarkers </h3>
                </li>
                <ul>
                  <p><b>This cluster contains terms related to breast cancer and diagnosis, such as different types of
                      breast carcinoma (DCIS, LCIS, ALCL), specific cell types (Toker cells, myofibroblastoma),
                      diagnostic techniques (STIR, rFOV), and treatments (motesanib, dyskerin). Therefore, I would label
                      this cluster as "Breast Cancer Diagnosis and Treatment".</b></p>
                  <!-- <p>Bioentities: 'MMPs', 'MT1-MMP', 'TIMP-2', 'uPA', 'TIMP-1', 'carcinomas', 'collagen', 'uPAR',
                    'steroid', 'matrix
                    metalloproteinases', 'tumor cell', 'MMP-1', 'MMP', 'PAI-1', 'carcinoma'</p> -->
                  <p>Bio Entities: 'LCH', 'mammary hamartoma', 'SA DCIS', 'Toker cells', 'mammary myofibroblastoma',
                    'LGASC', 'HCWs', 'IFLBC', 'ABDE', 'MGACA', 'Ag-NORs', 'MIDC', 'nonpalpable breast carcinoma',
                    'ICPC', 'AdCCs', 'NPBL', '99mTc phytate', 'NC-LCIS', 'feruglose', 'OMSP', 'STIR', 'STK1', 'P/F
                    LCIS', 'rFOV', 'breast-ALCL', 'microRNA20b', 'SMSGs', 'gadoteric acid', 'IFX', 'gadofosveset',
                    'dyskerin', 'ECAD', '(89)Sr', 'MnDPDP', 'AP-LCIS', 'DMIST', 'CRMc', 'ALNMs', 'motesanib', 'FBLs',
                    '3CB', 'IMPCa', 'ASLN', 'microRNA320a', 'NMMN', 'Resovist', 'REIS', "anti-CEA Fab'", 'MSGCs', 'c
                    Kit'</p>
            </p>
            </ul>
            </ul>
          </div>
        </div>
        <!--END Text with Iframe-->
      </div>
    </div>
  </div>
  <div class="footer-container">
<div class="banner">
  <div class="banner-table flex-column">
    <div class="flex-row">
      <div class="flex-item flex-column">
        <h2>Contact</h2>
        <p class="text add-bottom-margin-large">
          Any question? Look at the <a href="https://github.com/jiaweixu98/MethodsDatasetsScientists"
            style="text-decoration:none;font-size:15px;color:#ffffff;"> <b>
              <i class="fa fa-github"></i> Github repository </b> for more information.
          </a>
        </p>
      </div>
    </div>
  </div>
</div>

  </div>
</body>

</html>